Empowered by Maverix, Biologist Pushes Ahead with Autism Study

“We wanted a platform where everyone in the lab worked with the same tools doing exactly the same thing so results would be reliable and easy to understand. The Maverix Analytic Platform gives us exactly what we need - statistics, different graphs, different ways to understand your data - everything that makes your data apply to you.”

Marian Mellén, Postdoctoral Fellow, Rockefeller University  

Stem Cell Crusader Offers Hope in Battle Against Neurological Diseases 

“With Maverix, the data are already analyzed so it doesn’t take a bioinformatics genius to interpret the data once we get it back. When we tried out Maverix, we were impressed. We decided that it was more cost-effective and probably more reliable to work with Maverix than to do it internally.”

Jeanne Loring, Professor, Scripps Research Institute

Highlighting New Biomarker Discovery Capabilities

“In our own work on ovarian cancer, we have been able to greatly accelerate our search for biomarkers by using the Maverix Analytic Platform, enabling us to progress rapidly from large, complex raw data sets to actionable insights and candidates of high interest in a matter of a few days rather than the weeks or months associated with typical collaborations.”

 Doug Taylor PhD, Professor and Vice Chair for Research, Department of Obstetrics and Gynecology at the University of Louisville School of Medicine

Maverix Complete Provides End-to-End NGS Solution

“The Maverix Complete solution allowed us to gain the advantages of using RNA-seq for expression analysis without having to invest a lot of time and money developing Next Generation Sequencing capabilities and expertise.  Maverix managed the entire library prep and NGS workflow for us, and provided us with extensive data analysis.”

 Matt Siegel, Principal Scientist, Ardelyx